Submitted by Anonymous (not verified) on 27 February 2026 - 11:50
Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Cabometyx, cabozantinib, Date of authorisation: 09/09/2016, Revision: 21, Status: Authorised